Digestive Diseases and Sciences

, Volume 54, Issue 3, pp 654–660 | Cite as

External Validation of the Platelet Count/Spleen Diameter Ratio for the Diagnosis of Esophageal Varices in Hepatitis C Virus-Related Cirrhosis

  • Adnan Agha
  • Eram Anwar
  • Kaukab Bashir
  • Vincenzo Savarino
  • Edoardo G. Giannini
Original Article


Background Screening for esophageal varices (EV) is an important part of the diagnostic workup of cirrhotic patients. Aims To independently validate the use of the platelet count/spleen diameter ratio for the non-invasive diagnosis of EV in patients with HCV-related cirrhosis and in a sub-group of patients with compensated disease. Methods A platelet count/spleen diameter ratio cut-off value of 909 was evaluated for the diagnosis of EV in the whole population (n = 311) and in patients with compensated disease alone (n = 114). Compensated disease was defined as the absence of ascites as detected by abdominal ultrasound in patients who are not on diuretics and absence of hepatic encephalopathy. Results In the whole cohort (EV prevalence 49.5%), the platelet count/spleen diameter ratio 909 cut-off value had 96.9% positive predictive value, 100% negative predictive value, and 98.4% efficiency for EV diagnosis. In compensated cirrhotics (EV prevalence 26.3%), the platelet count/spleen diameter ratio 909 cut-off showed an excellent negative predictive value (100%) and a positive predictive value of 93.8%. for the diagnosis of EV. Conclusions In patients with HCV-related cirrhosis, the platelet count/spleen diameter may be proposed as a non-invasive tool for EV diagnosis, especially in financially deprived developing countries.


Esophageal varices Cirrhosis Platelet count Spleen diameter 



The authors wish to thank Professor Jayant A. Talwalkar, M.D., M.P.H., for his helpful suggestions and critical revision of the manuscript.


  1. 1.
    Hepatitis C (1997) Global prevalence. Wkly Epidemiol Rec 72:341–344Google Scholar
  2. 2.
    Sahara AI, Hunt CM, Hamilton JD (1996) Hepatitis C. Ann Intern Med 125:658–668Google Scholar
  3. 3.
    Fattovich G, Giustina G, Degos F, Tremolada F, Diodati G, Almasio P et al (1997) Morbidity and mortality in compensated cirrhosis type C: a retrospective follow-up study of 384 patients. Gastroenterology 112:463–472. doi:10.1053/gast.1997.v112.pm9024300 PubMedCrossRefGoogle Scholar
  4. 4.
    Gentilini P, Laffi G, La Villa G, Romanelli RG, Buzzelli G, Casini-Raggi V et al (1997) Long course and prognostic factors of virus-induced cirrhosis of the liver. Am J Gastroenterol 92:66–72PubMedGoogle Scholar
  5. 5.
    No Authors listed (1998) Prediction of the first variceal hemorrhage in patients with cirrhosis of the liver and esophageal varices. A prospective multicenter study. The North Italian Endoscopic Club for the Study and Treatment of Esophageal Varices. N Engl J Med 319:983–989Google Scholar
  6. 6.
    D’Amico G, Pagliaro L, Bosch J (1995) The treatment of portal hypertension: a meta-analytic review. Hepatology 22:332–354. doi:10.1002/hep.1840220145 PubMedGoogle Scholar
  7. 7.
    Rukhsana JF, Javed IF, Masood R, Hameed A, Farooq A, Sultan G (2005) Outcome after injection sclerotherapy for esophageal variceal bleeding in patients with liver cirrhosis and COPD. J Postgrad Med Inst 19:76–80Google Scholar
  8. 8.
    Salerno F, Borroni G, Moser P, Sangiovanni A, Almasio P, Budillon G et al (1996) Prognostic value of the galactose test in predicting survival of patients with cirrhosis evaluated for liver transplantation. A prospective multicenter Italian study. AISF Group for the Study of Liver Transplantation. Associazione Italiana per lo Studio del Fegato. J Hepatol 25:474–480. doi:10.1016/S0168-8278(96)80206-6 PubMedCrossRefGoogle Scholar
  9. 9.
    de Franchis R (2005) Evolving consensus in portal hypertension report of the Baveno IV consensus workshop on methodology of diagnosis and therapy in portal hypertension. J Hepatol 43:167–176. doi:10.1016/j.jhep. 2005.05.009 PubMedCrossRefGoogle Scholar
  10. 10.
    Garcia-Tsao G, Sanyal AJ, Grace ND, Carey WD; Practice Guidelines Committee of American Association for Study of Liver Diseases; Practice Parameters Committee of American College of Gastroenterology (2007) Prevention and management of gastroesophageal varices and variceal hemorrhage in cirrhosis. Am J Gastroenterol 102:2086–2102. Erratum in Am J Gastroenterol 102:2868. doi:10.1111/j.1572-0241.2007.01681.x Google Scholar
  11. 11.
    Spiegel BM, Targownik L, Dulai GS, Gralnek IM (2003) Endoscopic screening for esophageal varices in cirrhosis. Is it ever cost effective? Hepatology 37:366–377. doi:doi:10.1053/jhep.2003.50050 PubMedCrossRefGoogle Scholar
  12. 12.
    Arguedas MR, Heudebert GR, Eloubeidi MA, Abrams GA, Fallon MB (2002) Cost-effectiveness of screening, surveillance, and primary prophylaxis strategies for esophageal varices. Am J Gastroenterol 97:2441–2452. doi:10.1111/j.1572-0241.2002.06000.x PubMedCrossRefGoogle Scholar
  13. 13.
    Merkel C, Marin R, Angeli P, Zanella P, Felder M, Bernardinello E, Cavallarin G, Bolognesi M, Donada C, Bellini B, Torboli P, Gatta A, Gruppo Triveneto per l’Ipertensione Portale (2004) A placebo-controlled clinical trial of nadolol in the prophylaxis of growth of small esophageal varices in cirrhosis. Gastroenterology. 127:476–484. doi:10.1053/j.gastro.2004.05.004 PubMedCrossRefGoogle Scholar
  14. 14.
    Chalasani N, Imperiale TF, Ismail A, Sood G, Carey M, Wilcox CM et al (1999) Predictors of large esophageal varices in patients with cirrhosis. Am J Gastroenterol 94:3285–3291. doi:10.1111/j.1572-0241.1999.1539_a.x PubMedCrossRefGoogle Scholar
  15. 15.
    Zaman A, Becker T, Lapidus J, Benner K (2001) Risk factors for the presence of varices in cirrhotic patients without a history of variceal hemorrhage. Arch Intern Med 161:2564–2570. doi:10.1001/archinte.161.21.2564 PubMedCrossRefGoogle Scholar
  16. 16.
    Madhotra R, Mulcahy HE, Willner I, Reuben A (2002) Prediction of esophageal varices in patients with cirrhosis. J Clin Gastroenterol 34:81–85. doi:10.1097/00004836-200201000-00016 PubMedCrossRefGoogle Scholar
  17. 17.
    Levy C, Zein CO, Gomez J, Soldevila-Pico C, Firpi R, Morelli G et al (2007) Prevalence and predictors of esophageal varices in patients with primary biliary cirrhosis. Clin Gastroenterol Hepatol 5:803–808. doi:10.1016/j.cgh.2007.02.031 PubMedCrossRefGoogle Scholar
  18. 18.
    Giannini E, Botta F, Borro P, Malfatti F, Fumagalli A, Testa E et al (2003) Relationship between thrombopoietin serum levels and liver function in patients with chronic liver disease related to hepatitis C virus infection. Am J Gastroenterol 98:2516–2520. doi:10.1111/j.1572-0241.2003.08665.x PubMedCrossRefGoogle Scholar
  19. 19.
    Giannini EG (2006) Review article: thrombocytopenia in chronic liver disease and pharmacologic treatment options. Aliment Pharmacol Ther 23:1055–1065. doi:10.1111/j.1365-2036.2006.02889.x PubMedCrossRefGoogle Scholar
  20. 20.
    Giannini E, Botta F, Borro P, Risso D, Romagnoli P, Fasoli A et al (2003) Platelet count spleen/diameter ratio: proposal and validation of a non-invasive parameter to predict the presence of oesophageal varices in patients with liver cirrhosis. Gut 52:1200–1205. doi:10.1136/gut.52.8.1200 PubMedCrossRefGoogle Scholar
  21. 21.
    Giannini EG, Botta F, Borro P, Dulbecco P, Testa E, Mansi C et al (2005) Application of the platelet count/spleen diameter ratio to rule out the presence of oesophageal varices in patients with cirrhosis: a validation study based on follow-up. Dig Liver Dis 37:779–785. doi:10.1016/j.dld.2005.05.007 PubMedCrossRefGoogle Scholar
  22. 22.
    Zimbwa TA, Blanshard C, Subramaniam A (2004) Platelet count/spleen diameter ratio as a predictor of oesophageal varices in alcoholic cirrhosis. Gut 53:1055PubMedGoogle Scholar
  23. 23.
    Plestina S, Pulanic R, Kralik M, Plestina S, Samarzija M (2005) Color Doppler ultrasonography is reliable in assessing the risk of esophageal variceal bleeding in patients with liver cirrhosis. Wien Klin Wochenschr 117:711–717. doi:10.1007/s00508-005-0424-x PubMedCrossRefGoogle Scholar
  24. 24.
    Jeon SW, Cho CM, Tak WY, Ryeom HK, Kweon YO, Kim SK et al (2006) The value of Doppler-ultrasonography and laboratory tests as non-invasive predictors of the presence of esophageal varices in patients with chronic liver disease. Korean J Gastroenterol 48:180–187PubMedGoogle Scholar
  25. 25.
    Kazemi F, Kettaneh A, N’kontchou G, Pinto E, Ganne-Carrie N, Trinchet JC, Beaugrand M (2006) Liver stiffness measurement selects patients with cirrhosis at risk of bearing large oesophageal varices. J Hepatol 45:230–235. doi:10.1016/j.jhep. 2006.04.006 PubMedCrossRefGoogle Scholar
  26. 26.
    Alempijevic T, Bulat V, Djuranovic S, Kovacevic N, Jesic R, Tomic D et al (2007) Right liver lobe/albumin ratio: contribution to non-invasive assessment of portal hypertension. World J Gastroenterol 13:5331–5335PubMedGoogle Scholar
  27. 27.
    Justice AC, Covinsky KE, Berlin JA (1999) Assessing the generalizability of prognostic information. Ann Intern Med 130:515–524PubMedGoogle Scholar
  28. 28.
    Giannini EG, Zaman A, Kreil A, Floreani A, Dulbecco P, Testa E et al (2006) Platelet count/spleen diameter ratio for the noninvasive diagnosis of esophageal varices: results of a multicenter, prospective, validation study. Am J Gastroenterol 101:2511–2519. doi:10.1111/j.1572-0241.2006.00401_6.x PubMedCrossRefGoogle Scholar
  29. 29.
    Franchis R, Pascal JP, Ancona E, Burroughs AK, Henderson M, Fleig W et al (1992) Definitions, methodology and therapeutic strategies in portal hypertension. a consensus development workshop, Baveno, Lake Maggiore, Italy, April 5 and 6, 1990. J Hepatol 15:256–261. doi:10.1016/0168-8278(92)90044-P PubMedCrossRefGoogle Scholar
  30. 30.
    Pugh RN, Murray-Lyon IM, Dawson JL, Pietroni MC, Williams R (1973) Transection of the oesophagus for bleeding oesophageal varices. Br J Surg 60:646–664. doi:10.1002/bjs.1800600817 PubMedCrossRefGoogle Scholar
  31. 31.
    Kamath PS, Kim WR; Advanced Liver Disease Study Group (2007) The model for end-stage liver disease (MELD). Hepatology 45:797–805. doi:10.1002/hep.21563 PubMedCrossRefGoogle Scholar
  32. 32.
    Zweig MH, Campbell G (1993) Receiver-operating characteristic (ROC) plots: a fundamental evaluation tool in clinical medicine. Clin Chem 39:561–77PubMedGoogle Scholar
  33. 33.
    Realdi G, Fattovich G, Hadziyannis S, Schalm SW, Almasio P, Sanchez-Tapias J et al (1994) Survival and prognostic factors in 366 patients with compensated cirrhosis type B: a multicenter study. J Hepatol 21:656–666. doi:10.1016/S0168-8278(94)80115-0 PubMedCrossRefGoogle Scholar
  34. 34.
    Giannini EG, Risso D, Testa R, Trevisani F, Di Nolfo MA, Del Poggio P, Benvegnù L, Ludovico Rapaccini G, Farinati F, Zoli M, Borzio F, Caturelli E, Italian Liver Cancer (ITA.LI.CA.) Group (2006) Prevalence and prognostic significance of the presence of esophageal varices in patients with hepatocellular carcinoma. Clin Gastroenterol Hepatol 4:1378–1384. doi:10.1016/j.cgh.2006.08.011 PubMedCrossRefGoogle Scholar
  35. 35.
    Khokhar N, Gill ML, Malik GJ (2004) General seroprevalence of hepatitis C and hepatitis B virus infections in population. J Coll Physicians Surg Pak 14:534–536PubMedGoogle Scholar
  36. 36.
    Bukhtiari N, Hussain T, Iqbal M, Malik AM, Qureshi AH, Hussain A (2003) Hepatitis B and C single and co-infection in chronic liver disease and their effect on the disease pattern. J Pak Med Assoc 53:136–140PubMedGoogle Scholar
  37. 37.
    Ahmad K (2004) Pakistan: a cirrhotic state? Lancet 364:1843–1844. doi:10.1016/S0140-6736(04)17458-8 PubMedCrossRefGoogle Scholar
  38. 38.
    Jensen DM (2002) Endoscopic screening for varices in cirrhosis: findings, implications, and outcomes. Gastroenterology 122:1620–1630. doi:10.1053/gast.2002.33419 PubMedCrossRefGoogle Scholar
  39. 39.
    Giannini EG, Botta F, Testa R (2004) Prediction of oesophageal varices with platelet count/spleen diameter ratio or platelets alone. Gut 53:914–915Google Scholar
  40. 40.
    Thabut D, Trabut JB, Massard J, Rudler M, Muntenau M, Messous D et al (2006) Non-invasive diagnosis of large oesophageal varices with FibroTest in patients with cirrhosis: a preliminary retrospective study. Liver Int 26:271–278. doi:10.1111/j.1478-3231.2005.01227.x PubMedCrossRefGoogle Scholar
  41. 41.
    Eisen GM, Eliakim R, Zaman A, Schwartz J, Faigel D, Rondonotti E et al (2006) The accuracy of PillCam ESO capsule endoscopy versus conventional upper endoscopy for the diagnosis of esophageal varices: a prospective three-center pilot study. Endoscopy 38:31–35. doi:10.1055/s-2005-921189 PubMedCrossRefGoogle Scholar
  42. 42.
    Talwalkar JA, Kamath PS (2001) Screening for esophageal varices among patients with cirrhosis of the liver. Am J Gastroenterol 96:3039–3040. doi:10.1111/j.1572-0241.2001.04692.x PubMedCrossRefGoogle Scholar
  43. 43.
    Kovalak M, Lake J, Mattek N, Eisen G, Lieberman D, Zaman A (2007) Endoscopic screening for varices in cirrhotic patients: data from a national endoscopic database. Gastrointest Endosc 65:82–88. doi:10.1016/j.gie.2006.08.023 PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2008

Authors and Affiliations

  • Adnan Agha
    • 1
  • Eram Anwar
    • 1
  • Kaukab Bashir
    • 1
  • Vincenzo Savarino
    • 2
  • Edoardo G. Giannini
    • 2
  1. 1.Department of Internal Medicine, Medical Unit I, Jinnah HospitalAllama Iqbal Medical CollegeLahorePakistan
  2. 2.Gastroenterology Unit, Department of Internal MedicineUniversity of GenoaGenoaItaly

Personalised recommendations